Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"pediatric systemic lupus erythematosus"

Slides: 1–8 of 8
Add to tray Remove from tray

Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: research evidence | comparative effectiveness review
Add to tray Remove from tray

Background: Causes of Musculoskeletal Pain

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | nonrheumatic cause | sprain | strain | overuse | normal body growth | rheumatic cause | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | spondyloarthropathy | enthesitis-related arthritis | juvenile ankylosing spondylitis | reactive arthritis | acute rheumatic fever | Henoch-Schönlein purpura
Add to tray Remove from tray

Background: Pediatric Lupus Erythematosus

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: pediatric systemic lupus erythematosus | autoimmune disease | inflammation | blood vessels | connective tissues | organs | incidence | prevalence | disease progression | immunosuppression
Add to tray Remove from tray

Clinical Questions Addressed by the CER (2 of 3)

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: key questions | clinical questions | clinical diagnosis | musculoskeletal pain | children | adolescents | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | test performance | test sensitivity | test specificity | positive predictive value | negative predictive value
Add to tray Remove from tray

Clinical Questions Addressed by the CER (3 of 3)

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: key questions | clinical questions | musculoskeletal pain | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | children | adolescents | age | sex | race | ethnicity | comorbidity | recent infection | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | test performance | test sensitivity | test specificity | positive predictive value | negative predictive value | referral decisions | clinical management | clinical uncertainty
Add to tray Remove from tray

Report Findings: Prevalence of Musculoskeletal Pain Among Healthy Children

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | nontraumatic pain | prevalence | healthy children | healthy adolescents | age | sex | headache | abdominal pain | recurrence predictors
Add to tray Remove from tray

Report Findings: Clinical Bottom Line Regarding the Utility of Clinical Testing

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: antinuclear antibody | cyclic-citrullinated peptide | juvenile idiopathic arthritis | musculoskeletal pain | negative predictive value | pediatric systemic lupus erythematosus | positive predictive value | rheumatoid factor | test performance | test sensitivity | test specificity | test utility | clinical testing
Add to tray Remove from tray

Conclusions (1 of 2)

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: adolescents | age | children | clinical assessment | juvenile idiopathic arthritis | noninflammatory pain | prevalence | sex | test sensitivity | test specificity | musculoskeletal pain
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364